Cosmetic or drug
On this page12
Two schemes, one jar
A topical can be assessed as a cosmetic or as a drug, and the labeling requirements differ substantially between them.
The warning in this property is a cosmetic requirement
It sits in part 740, which is cosmetic labeling. Nothing on these pages says it reaches a product assessed otherwise.
And the drug route has its own panel
The hair care property covers it: an over-the-counter monograph and a Drug Facts panel with its own content and proportion rules, which are far more demanding of label area.
Claims are what move a product between them
Which is a marketing copy decision with a labeling consequence, the same shape as the representation element in the adjacent botanicals property.
So the copy decision precedes the container decision
Because a Drug Facts panel needs far more room than a cosmetic warning, and 49 of the 106 containers here are wider than they are tall.
This property does not make the determination
Not for any product and not for any claim. It is a question for someone qualified, and the answer changes which rules apply.
Nor does it address the ingredient
Whether a cannabinoid is permitted in a cosmetic, and what federal agencies have said about it, is outside this property entirely.
Or state law
Which differs state by state for these products and which a national catalog cannot speak to.
What it does give you
An exact warning string, an exact minimum letter height, the dimensions of every container, and an honest account of what is not on the shelf.
And the two schemes are not a menu
A maker does not choose which one applies. The product and the claims decide it, and the labeling follows from the decision rather than informing it.
Settle the scheme first
Then plan the panel, then pick the container. Doing it in the other order means discovering a panel will not fit after the mold has been chosen.